
    
      Patients with uncontrolled cancer pain despite treatment of oral morphine equivalent â‰¥100
      mg/d will be randomly assigned to oral opioids to transdermal fentanyl (rotation group) or
      oral oxycodone plus fentanyl (combination group). Patients answer a questionnaire that
      included pain severity (0 to 10) and interference items at baseline and after one week.
      Primary outcomes are change in pain score and treatment success.
    
  